High CRYAB expression represents an independent molecular marker for unfavorable outcomes in ovarian cancer patients and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells [29]. Here, TNFSF10 is linked to ovarian carcinoma.